ADYNXX, INC.

Profile

Company Names

ADYNXX, INC.
ADYNXX INC

Addresses

100 PINE STREET, SUITE 500, SAN FRANCISCO, CA 94104

665 3RD STREET, SUITE 250, SAN FRANCISCO, CA 94107

Phone Numbers

415 512-7740
858-472-6032

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$21,583,515.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-12-20 
$15,999,999.00 
$15,999,999.00 
$0.00 
Equity 
3
2010-12-09 
$4,803,858.00 
$15,803,857.00 
$10,999,999.00 
Equity 
2
2008-08-01 
$39,098.00 
$39,098.00 
$0.00 
Equity 
1
2007-11-08 
$740,560.00 
$740,560.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STAN 
 
ABEL 
DIRECTOR
CORTHERA INC   |  ADYNXX INC   |  SITEONE THERAPEUTICS, INC.   |  ADYNXX, INC.
MICHAEL 
 
ASHLEY 
DIRECTOR
ADYNXX INC
GEORGE 
 
BARNETT 
DIRECTOR, EXECUTIVE OFFICER
ADYNXX INC
SCOTT 
 
HARRIS 
EXECUTIVE OFFICER
ROGERS-SE OHIO DEVELOPMENT   |  ORIGINAL BROOKLYN WATER BAGEL CO., INC.   |  DANCEWEAR HOLDINGS, LLC   |  EJV 5-6   |  BROOKLYN WATER ENTERPRISES, INC.   |  CHEROKEE COUNTY OFFSET   |  MULTI-WELL PROVEN DEVEL0PMENT   |  MULTI-ZONE HORIZONTAL PUD   |  MILAM HORIZONTAL 2   |  ROCKDALE 36 DEVELOPMENT   |  PRIORITY ENDEAVORS, LLC   |  ADYNXX, INC.   |  MCRT REAL ESTATE INVESTMENT TRUST, INC.   |  MCRT2 REAL ESTATE INVESTMENT TRUST, INC.   |  MCRT3 REAL ESTATE INVESTMENT TRUST, INC.
HEATH 
 
LUKATCH 
DIRECTOR
INOGEN INC   |  ANAPTYSBIO INC   |  CIANNA MEDICAL INC   |  ELEVATION PHARMACEUTICALS INC   |  FLEXION THERAPEUTICS INC   |  SPINIFEX PHARMACEUTICALS INC   |  SATSUMA PHARMACEUTICALS, INC.   |  ADYNXX, INC.   |  ENGAGE THERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  HALO NEURO INC.   |  SUTROVAX, INC.   |  VIACYTE INC.   |  CARGO THERAPEUTICS, INC.   |  MAGNUS MEDICAL, INC.
JULIEN 
 
MAMET 
EXECUTIVE OFFICER, DIRECTOR
ADYNXX INC   |  ADYNXX, INC.
DONALD 
 
MANNING 
EXECUTIVE OFFICER
DENTON HOSPITAL INVESTORS, LP   |  ADYNXX, INC.
RICK 
 
ORR 
EXECUTIVE OFFICER, DIRECTOR
ADYNXX INC   |  ATX INNOVATION, INC.   |  REAL SAVVY, INC.   |  SITEONE THERAPEUTICS, INC.   |  ADYNXX, INC.   |  EXALYS THERAPEUTICS, INC.
DENNIS 
 
PODLESAK 
DIRECTOR
CORTHERA INC   |  REGADO BIOSCIENCES INC   |  SYNDAX PHARMACEUTICALS INC   |  ADYNXX INC   |  KALIDEX PHARMACEUTICALS, INC.   |  RIGHTCARE SOLUTIONS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
ECKARD 
 
WEBER 
DIRECTOR
SEQUEL PHARMACEUTICALS INC   |  TOBIRA THERAPEUTICS, INC.   |  ASCENTA THERAPEUTICS, INC.   |  ADYNXX INC   |  TRAGARA PHARMACEUTICALS, INC.   |  OCERA THERAPEUTICS, INC.   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  OREXIGEN THERAPEUTICS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-01-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-20 
2010-12-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-09 
2010-12-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-08-01 
2010-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2007-11-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#